Speaker

Naga P Chalasani

Indiana University Medical Center
Naga P Chalasani

Biography

Dr. Naga Chalasani currently serves as David W. Crabb Professor of Medicine and Vice President for Academic Affairs at Indiana University School of Medicine and Indiana University Health. He previously served as the Director of the Division of Gastroenterology and Hepatology (2007-2020) and Chair of the Department of Medicine (2020-2021, interim) at Indiana University School of Medicine. He received his MBBS in Kakatiya Medical College (1981-1987) and completed his internal medicine residency (1991-1994) and Gastroenterology and Hepatology fellowship (1994-1997) at Emory University in Atlanta, USA. His research is focused on nonalcoholic fatty liver disease (NAFLD) and drug induced liver injury (DILI) and has been continuously funded by the National Institutes of Health since 1999.

Sessions

7:00 AM - 7:45 AM
Nov 16 2024
San Diego, CA

MTE #2: Hepatotoxicity in Drug Development: A Regulatory Perspective (Ticketed)

Acute Liver Failure
Acute-on-Chronic Liver Failure
Drug-Induced Liver Injury
9:45 AM - 10:45 AM
Nov 17 2024
San Diego, CA

Designing Clinical Trials for Alcohol-Associated Liver Disease

Gyongyi Szabo, MD, PhD, FAASLD, Presenter
Gene Y Im, MD, FAASLD, Presenter
Jessica Mellinger, MD, MSc, Presenter
Naga P Chalasani, Presenter
Frank A Anania, MD, FAASLD, FACP, AGAF, Presenter
ALD
11:00 AM - 12:30 PM
Nov 17 2024
San Diego, CA

American Association for the Study of Liver Diseases and Latin American Association for the Study of the Liver Joint Symposium: Challenges in Drug-Induced Liver Injury, a Tale of Two Continents

Fernando Bessone Professor, MD, PhD, Presenter
Dina Halegoua-DeMarzio, MD, Presenter
Naga P Chalasani, Presenter
Nelia Hernandez, MD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
Drug-Induced Liver Injury
12:30 PM - 1:00 PM
Nov 18 2024
San Diego, CA

The Genetic Architecture of SLD: Pioneering New Frontiers in Advanced Liver Disease